---
edited: 2024-03-02
tags:
---
### Introduction
- [[Autosomal recessive]] in [[Chromosome 12]]

### Types and pathogenesis

| Type         | Cause                                      |
|--------------|--------------------------------------------|
| Type I       | Deficiency of phenylalanine hydroxylase   |
| Type II & III| Deficiency of dihydrobiopterin reductase  |
| Type IV & V  | Deficiency of enzymes synthesizing biopterin |

##### Severity grading
- **Complete enzyme deficiency** results in classic phenylketonuria (PKU; untreated serum phenylalanine concentrations of >1200 micromol/L (20 mg/dL) and elevated urine phenylketones.

- **Residual enzyme activity** causes:
	- Moderate PKU (phenylalanine concentrations 900 to 1200 micromol/L)
	- Mild PKU (600 to 900 micromol/L)
	- Mild HPA (360 to 600 micromol/L)
	- Benign mild HPA not requiring treatment (120 to 360 micromol/L)

| Upstream Accumulation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | Downstream Deficiency                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| - Phenylalanine which gets converted into phenylketones like phenyl lactate, pyruvate, and acetate<br>- Eczema-like rashes<br>- Neurotoxicity:<br>  - Some metabolites of phenylalanine, such as phenylpyruvate and phenylacetate, have neurotoxic effects and can contribute to the neurological manifestations of PKU.<br>  -[[Seizures]], epilepsy, Global developmental delay, Hypertonia, abnormal posturing, [[Failure to thrive]] <br>- Musty odor of urine due to phenylacetic acid in sweat and urine | Tyrosine becomes nutritionally essential<br>Catecholamines deficiency<br>  - Decreased DA, NA: [[Global developmental delay]]<br>decreased [[Melanin synthesis]]: leads to hypopigmentation <br>Impaired Synthesis of Neurotransmitters: Phenylalanine is a precursor for the synthesis of neurotransmitters such as dopamine, norepinephrine, and serotonin. In PKU, the deficiency of tyrosine, which is derived from phenylalanine, can lead to impaired synthesis of these neurotransmitters, affecting mood, cognition, and behavior. |
![[Pasted image 20240120192719.png]]

### Diagnosis

| Modality                   | Techniques/findings                                                                                                                                |     |
| -------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------- | --- |
| Newborn screening          | - [[tandem mass spectrometry]]<br>- Phenylalanine on 2-3rd day after birth                                                                         |     |
| If screening test positive | [[Oral Tetrahydrobiopterin (BH4) loading test]]                                                                                                    |     |
| Molecular analysis         | confirm the diagnosis of PKU through identification of two pathogenic mutations in the _PAH_ gene (homozygous or compound heterozygous mutations). |     |
| FeCl3 test                 | Increased Phenylpyruvate in urine                                                                                                                  |     |
| Guthrie's test             | Uses Bacillus subtilis                                                                                                                             |     |
| Imaging                    | Pallor in prefrontal cortex, hippocampal relay circuits                                                                                            |     |
| Pathology                  | Abnormal [[Myelination]]                                                                                                                           |     |
| Tyrosine concentrations    | typically in the normal range, although, occasionally, low concentrations are observed                                                             |     |
| Enzyme analysis            | not performed to confirm the diagnosis, because PAH activity is expressed only in the liver.                                                       |     |

### Management

| Intervention                             | Description                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| ---------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Low phenylalanine and high tyrosine diet | Avoid High protein foods<br>No limit in low protein food <br>Medium protein food: Need to count protein (< 2 g)<br>Avoid [[Aspartame]]<br>[[Tetrahydrobiopterin deficiency]] due to reductase deficiency should be supplemented<br>Long-chain PUFA<br>Large neutral amino acids: <br>		- LNAAs (arginine, histidine, isoleucine, leucine, lysine, methionine, threonine, tryptophan, tyrosine, and valine) compete with phenylalanine for the same amino transporter at the blood-brain barrier.<br>		- Supplementation with LNAAs may therefore significantly reduce the influx of phenylalanine into the brain in patients with PKU |
| Drugs                                    | - Kuvan: Cofactor for PAH which increases tolerance<br>- Palynziq: Metabolizes Phenylalanine<br>- Tetrahydrobiopterin/Sapropterin: biologically active synthetic form of BH4                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Monitoring                               | - weekly intervals during the first year, twice monthly from 1 to 12 years of age, and monthly after 12 years of age<br>- recommended maintaining a blood concentration of 2 to 6 mg/dL (120 to 360 micromol/L) for affected children through 12 years of age and 2 to 15 mg/dL (120 to 900 micromol/L) after 12 years of age                                                                                                                                                                                                                                                                                                         |

### Related
- [[Phenylalanine Embryopathy]] 